# Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas

> **NCT01849952** · — · TERMINATED · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 94 (actual)

## Conditions studied

- Astrocytoma
- Oligodendroglioma
- Oligoastrocytoma
- Anaplastic Astrocytoma
- Anaplastic Oligodendroglioma
- Anaplastic Oligoastrocytoma
- Glioblastoma
- Brain Tumors
- Brain Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01849952
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2013-10-09
- **Primary completion:** 2024-04-12
- **Final completion:** 2025-08-25
- **Target enrollment:** 94 (ACTUAL)
- **Why stopped:** Study was administratively closed by IRB
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01849952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01849952, "Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01849952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*